Nanotechnology News and Research

RSS

Sprayable gel could help prevent recurrences of cancer after surgery

Many people who are diagnosed with cancer will undergo some type of surgery to treat their disease -- almost 95 percent of people with early-diagnosed breast cancer will require surgery and it's often the first line of treatment for people with brain tumors, for example.

11 Dec 2018

Researchers discover a 'blind spot' in atomic force microscopy

Researchers have discovered a 'blind spot' in atomic force microscopy - a powerful tool capable of measuring the force between two atoms, imaging the structure of individual cells and the motion of biomolecules.

10 Dec 2018

Scientists develop nanoscale tweezers that can move freely within cells

Researchers have developed nanoscale “tweezers” that can extract cellular components such as DNA, proteins, and organelles, without causing damage or bursting the cell.

3 Dec 2018

NanoSphere develops new intraoral product that has potential to revolutionize cannabis therapies

NanoSphere Health Sciences Inc. is pleased to announce the Company has developed a new intraoral delivered cannabis product for the Canadian market, which produces similar effects to smoking cannabis, but is safer and more effective than edibles.

26 Nov 2018

Merck declares 2018 Life Science Award winners

Merck, the vibrant science and technology company, recognized three graduate students who have demonstrated innovation in life science at an awards ceremony at the company’s global headquarters in Darmstadt, Germany recently.

From Merck 20 Nov 2018

Breakthrough technology offers new hope to people with glaucoma, retinitis and macular degeneration

In January 2009, the life of engineer Michel Meunier, a professor at Polytechnique Montréal, changed dramatically. Like others, he had observed that the extremely short pulse of a femtosecond laser (0.000000000000001 second) could make nanometer-sized holes appear in silicon when it was covered by gold nanoparticles.

20 Nov 2018

First fully personalized tissue implant engineered from patient's own materials and cells

In a new study, Tel Aviv University researchers reveal how they invented the first fully personalized tissue implant, engineered from a patient's own materials and cells. The new technology makes it possible to engineer any kind of tissue implant from one small fatty tissue biopsy.

13 Nov 2018

Purdue researchers invent new smart drainage device to help glaucoma patients

Purdue University researchers have invented a new smart drainage device to help patients with glaucoma, a leading cause of blindness in the world, as they try to save their eyesight.

9 Nov 2018

New nano-immunotherapy promotes long-term acceptance of transplanted organs

Researchers at the Mount Sinai School of Medicine have developed a new nanotechnology-based immunotherapy that promotes long-term transplant acceptance in an animal model.

7 Nov 2018

Promising potential of stimuli-responsive nanomaterial for cancer therapy

Nanosystems that deliver anticancer drugs or imaging materials to tumors are showing significant progress, particularly those that respond to tumor-related stimuli, according to a review published in the journal Science and Technology of Advanced Materials.

30 Oct 2018

Quantum dot-based FISH method enhances cell imaging

A team of researchers from the University of Illinois at Urbana-Champaign and Mayo Clinic have engineered a new type of molecular probe that can measure and count RNA in cells and tissue without organic dyes.

30 Oct 2018

Researchers engineer new 'smart' repellent surface coatings

Researchers at McMaster University have solved a vexing problem by engineering surface coatings that can repel everything, such as bacteria, viruses and living cells, but can be modified to permit beneficial exceptions.

24 Oct 2018

NJIT team wins two major international awards for vision therapy platform

An NJIT-led team of engineers, game designers, artists and clinicians won two major international awards for its vision therapy platform, including "most innovative breakthrough," at the 2018 Augmented World Expo Europe, the leading industry conference for augmented reality technology.

24 Oct 2018

Using nanotechnology to fight dementia

In the human brain, nerve cells - so-called neurons - care for the transmission of electrical signals. They form the functional component responsible for sensations, stimuli and memories. In the presence of dementia, there is an adsorption of proteins outside the neurons, which then leads to the death of the neuronal cells. How to prevent the death of neurons is still the subject of scientific research today.

10 Oct 2018

Researchers devise a simple way to boost efficacy of malarial TBVs

For decades, scientists have been trying to develop a vaccine that prevents mosquitoes from spreading malaria among humans.

9 Oct 2018

Scientists develop micron-sized spheres that catch and destroy contaminants in water

Rice University scientists have developed something akin to the Venus' flytrap of particles for water remediation.

6 Oct 2018

Natural nanoscopic particles identified as possible diagnostic tool for Alzheimer's

Exosomes are natural nanoscopic particles released by most cell types, and are currently the focus of research because they represent a possible tool for the diagnosis of Alzheimer's. These particles are not so easy to isolate, and nanotechnology may help in this process.

3 Oct 2018

Nanoparticles show promise in treatment for triple-negative breast cancer, finds study

Approximately 10-20 percent of diagnosed breast cancers are found to be triple-negative, meaning the breast cancer cells test negative for estrogen and progesterone receptors as well as HER2 receptors, genes that can play a role in the development of breast cancer.

1 Oct 2018

CytoSen receives favorable response from FDA to its pre-IND meeting package for CSTD002-NK

CytoSen Therapeutics, a private biopharmaceutical company accelerating innovation in Natural Killer cell therapy, today announced it has received a favorable response from the U.S. Food and Drug Administration to its pre-Investigational New Drug meeting package for the proposed Phase 2 trial of CytoSen's adoptive NK cell therapy, CSTD002-NK, for the reduction of relapse in high risk acute myeloid leukemia or myelodysplastic syndrome in patients undergoing haploidentical hematopoietic stem cell transplantation.

27 Sep 2018

NIAID releases strategic plan to expand knowledge of TB by using modern tools

Tuberculosis (TB) is the leading infectious cause of death worldwide, killing roughly 1.6 million people in 2017. In the past 200 years, TB claimed the lives of more than one billion people--more deaths than from malaria, influenza, smallpox, HIV/AIDS, cholera and plague combined.